Commentary: Limitations of the pig-to-non-human primate islet transplantation model

Xenotransplantation

Volumn 20, Issue 1, 2013, Pages 2-4

  Wijkstrom, Martin ^a   Bottino, Rita ^a,b   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXPERIMENTAL MODEL; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; NOTE; PANCREAS ISLET TRANSPLANTATION; PIG TO NONHUMAN PRIMATE ISLET TRANSPLANTATION MODEL; PRIMATE; PRIORITY JOURNAL; SWINE; VASCULAR ACCESS; XENOTRANSPLANTATION; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; HUMAN; METHODOLOGY; XENOGRAFT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84873467019     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/xen.12017     Document Type: Note

References (20)

1. Graham M, Schuurman H-J,. The usefulness and limitations of the diabetic macaque model in evaluating long-term porcine islet xenograft survival. Xenotransplantation 2012; Nov 29 [Epub ahead of print].
2. Cooper DKC, Bottino R, Satyananda V, Wijkstrom M, Trucco M,. Towards clinical islet xenotransplantation: are revisions to the IXA guidelines warranted? (Commentary). Xenotransplantation 2013. In press.
3. Casu A, Bottino R, Balamurugan AN, et al. Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 2008; 51: 120-129.
4. Graham ML, Bellin MD, Papas KK, Hering BJ, Schuurman HJ,. Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation. Xenotransplantation 2011; 18: 328-342.
5. Bennet W, Sundberg B, Lundgren T, et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000; 69: 711-719.
6. van der Windt DJ, Marigliano M, He J, et al. Islet damage after direct exposure of pig islets to blood-has humoral immunity been underestimated? Cell Transplant 2012; 21: 1791-1802.
7. Martin B, Thompson P, Lowe M, et al. Novel dual transplant model: In vivo evaluation of Gal-deficient and wild-type xenoislet preparations within a single recipient. Poster presentation (P94) at the American Transplant Congress, Boston, MA, June 2012.
8. van der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DKC,. Rapid loss of intraportally-transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 2007; 14: 288-297.
9. Yasunami Y, Lacy PE, Finke EH,. A new site for islet transplantation-a peritoneal-omental pouch. Transplantation 1983; 36: 181-182.
10. Echeverri GJ, McGrath K, Bottino R, et al. Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. Am J Transplant 2009; 9: 2485-2496.
11. Kramp RC, Cuche R, Renold AE,. Subcutaneous, isogeneic transplantation of either duct-ligated pancreas or isolated islets in streptozotocin diabetic mice. Endocrinology 1976; 99: 1161-1167.
12. Dufrane D, Goebbels RM, Gianello P,. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 2010; 90: 1054-62.
13. Pedraza E, Brady AC, Fraker CA, et al. Macroporous three dimensional PDMS scaffolds for extrahepatic islet transplantation. Cell Transplant 2012; Oct 2 [Epub ahead of print].
14. Komori J, Boone L, DeWard A, Hoppo T, Lagasse E,. The mouse lymph node as an ectopic transplantation site for multiple tissues. Nat Biotechnol 2012; 30: 976-983.
15. Hering BJ, Cooper DKC, Cozzi E, et al. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Executive summary. Xenotransplantation 2009; 16: 196-202.
16. Cooper DKC, Casu A,. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Chapter 4: pre-clinical efficacy and complication data required to justify a clinical trial. Xenotransplantation 2009; 16: 229-238.
17. Zhou H, van der Windt DJ, Dons EM, et al. A syndrome of severe hypoglycemia and acidosis in young immunosuppressed diabetic monkeys and pigs-association with sepsis. Transplantation 2012; 94: 1187-1191.
18. Gaber AO, Fraga D, Kotb M, Lo A, Sabek O, Latif K,. Human islet graft function in NOD-SCID mice predicts clinical response in islet transplanted recipients. Transplant Proc 2004; 36: 1108-1110.
19. Sabek OM, Fraga DW, Minoru O, McClaren JL, Gaber AO,. Assessment of human islet viability using various mouse models. Transplant Proc 2005; 37: 3415-3416.
20. Xu BY, Yu Y, Al-Abdullah IH, Kandeel F, Hering B, Wright JR Jr,. Long-term survival and function of intraportal porcine and human islet xenografts in nondiabetic nude mice. Transplant Proc 2008; 40: 584-586.